Estimation of Ketorolactromithamine in Phamaceutical Samples and Biofluids by The New Validated UPLC Method
Mohammad Nasir Uddin, Monir Uddin, Md. Touhidul Kabir, Suman Das
J. Pure App. Chem. Res. Vol 6, No 2 (2017), pp. 137-149
Submitted: January 19, 2017     Accepted: April 27, 2017     Published: May 06, 2017


Cover Image

A new UPLC method has been described to determine ketorolac tromethamine in pharmaceutical samples and biofluids. Drug was eluted using a reversed-phase Gemini 3U, C18, 110R (150 × 4.6 mm, 3 μm) column when a mobile phase composition 90:05:05 (v/v) consisting CH3OH, CH3CN and NaH2PO4 under isocratic program.Ketorolac tromethamine was eluted at a short of time 2.02 min. Ketorolac tromethamine isolated from biofluids after liquid-phase extraction. The results were linear up to 10 µg mL-1 with the correlation coefficients greater than 0.999. The sensitivity limits, LOD and LOQ were 0.016 and 0.051 µg mL-1, respectively. The method is simple, fast and reliable with good specificity and sensitivity and will be suitable for routine analysis of ketorolac tromethamine.

Keywords : Ketorolac tromethamine, pharmaceutical samples and biofluids, UPLC method
Full Text: PDF


[1] Rang H, Dale M, Ritter J and Flower R, Pharmacology, 6th Ed., Churchill Livingstone, Elsevier, 2007, 227-230.

[2] Wang Z, Dsida R., and Avram M. J., J. Chromatogr. B, 2001, 755(1-2), 383-386.

[3] Warner T. D., Mitchell J. A., FASEB J, 2004, 18, 790-804.

[4] Galán-Herrera J. F., Poo J. L., Maya-Barrios J. A., de Lago A., Oliva M. S. I., . Mario González-de la P., Patricia J., Ericka L., Victoria B., Salvador N., Clin Ther, 2008, 30, 1667-1674.

[5] Dave, J. B., P. J. Vyas, C. N. Patel, Chron. Young Sci., 2013, 4(1), 24-31.

[6] Martindale, The Complete Drug Reference, 35th Edition, 2004, London, Pharmaceutical Press.

[7] Committee on the Safety of Medicines and Medicines Control Agency, Curr. Prob. Pharmacovigilance, 1993, 19, 5-8.

[8] Strom BL, Berlin JA, Kinman JL, Spitz PW, Hennessy S, Feldman H, Kimmel S, Carson L, JAMA, 1996, 275, 376-82.

[9] R Singh, APathak, P Chawla, Indian J. Pharm. Biol. Res., 2013, 1(4), 95-101.

[10] Bhagyashree R. D., K. P. Bhusari, M. R. Tajne, M. H. Ghante, N. S. Jain, Indo American Journal of Pharm Research. 2014, 4(7), 3248-3257.

[11] Razzaq S. N., Khan I. U., Quim. Nova. 2012, 35(6), 1216-1221.

[12] Jayant B. Dave, Pratik J. Vyas, Chhagan N. Patel, Chron. Young Sci., 2013, 4(1), 24-31.

[13] Chaudhary R, Gangwal S, Jindal K and Khanna S, J. Chromatogr. B, 1993, 614(1), 180-184.

[14] Jones D and Bjorksten A, J. Chromatogr. B, 1994, 661(1), 165-167.

[15] M. N. Uddin, S. Das, S. H. Khan, S. K. Shill, H. R. Bhuiyan, R. Karim, J Taibah Univ Sci, 2016, 10(5), 755-765.

[16] Patri, S., A. K. Patni, S. S. Iyer, A. H. Khuroo, T. Monif, S. Rana, S. Kumar, and R. Jain, Chrom. Res. International, 2011, 2011, 1-11.

[17] Logan, B. K., Friel, N. P., Peterson, K. L., Predmore, B. B., J. Anal. Toxicol., 1995, 19, 61.

[18] ICH Harmonized Tripartite (1996) Validation of Analytical Procedures: Text and Methodology Q2 (R1), Current Step 4 Version, Parent Guidelines on Methodology Dated November 6 1996, Incorporated in November In: International Conference on Harmonisation, 2005, Geneva, Switzerland.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.